サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1773905

小容量非経口薬の世界市場

Small Volume Parenteral

出版日
ページ情報
英文 483 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.42円
小容量非経口薬の世界市場
出版日: 2025年07月22日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 483 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

小容量非経口薬の世界市場は2030年までに2,775億米ドルに達する見込み

2024年に1,884億米ドルと推定される小容量非経口薬の世界市場は、2024年から2030年にかけてCAGR 6.7%で成長し、2030年には2,775億米ドルに達すると予測されます。本レポートで分析したセグメントの一つである液体は、CAGR7.7％を記録し、分析期間終了時には1,920億米ドルに達すると予想されます。乾式セグメントの成長率は、分析期間中CAGR 4.6％と推定されます。

米国市場は推定513億米ドル、中国はCAGR10.7%で成長予測

米国の小容量非経口薬市場は、2024年に513億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに581億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは10.7%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.2%と6.5%と予測されています。欧州では、ドイツがCAGR 4.4%で成長すると予測されています。

世界の小容量非経口薬市場- 主要動向と促進要因のまとめ

なぜ小容量非経口薬の需要が増加しているのか？注射ドラッグデリバリーにおける役割の理解

小容量非経口薬（SVP）製剤は、現代医療において重要な役割を果たしており、幅広い治療用途に効率的かつ制御されたドラッグデリバリーを提供しています。通常、バイアル、アンプル、またはプレフィルドシリンジに包装されたこれらの注射製剤は、ワクチン、生物製剤、抗生物質、疼痛管理薬などの重要な治療に使用されています。糖尿病、心血管疾患、自己免疫疾患などの慢性疾患の有病率の増加は、これらの疾患の多くが定期的な注射治療を必要とするため、SVPの需要を大幅に増加させています。さらに、モノクローナル抗体や細胞療法を含む生物学的製剤開発の進歩は、個別化医療におけるSVPの使用をさらに拡大しています。ヘルスケア・プロバイダーは、薬物吸収の速さと標的治療を重視しており、小容量非経口薬ソリューションの採用は、病院、クリニック、在宅医療の現場で増え続けています。

技術革新は小容量非経口薬製造にどのような変化をもたらしているのでしょうか？無菌処理と薬剤安定性の進歩を探る

小容量非経口薬ソリューションの製造は、無菌処理、先進パッケージング、薬剤安定性の技術的進歩とともに進化してきました。閉鎖系無菌充填を含む充填仕上げ技術の革新は、汚染リスクを低減しながら無菌性保証を改善しました。さらに、代替ガラスやポリマーベース容器などの先進パッケージング材料の使用により、薬剤の安定性と保存性が向上しています。プレフィルドシリンジや自動注射器の台頭は、患者の利便性をさらに向上させ、手作業による薬剤調製の必要性を減らし、投与ミスを最小限に抑えています。AIを活用した品質管理システムやリアルタイムモニタリング技術も生産効率を最適化し、規制遵守と製品の一貫性を確保しています。製薬企業が自動化とスマート製造への投資を続ける中、小容量非経口薬市場は費用対効果、拡張性、安全性の向上を目の当たりにしています。

小容量非経口薬市場に影響を与える課題とは？サプライチェーンの制約、規制遵守、生産コストへの対応

小容量非経口薬製剤の需要が伸びているにもかかわらず、市場はサプライチェーンの混乱、規制のハードル、製造コストの高さに関する課題に直面しています。医薬品のサプライチェーンは、特にガラスバイアル、無菌注射剤、特殊な賦形剤などの原材料不足の影響を受けています。さらに、適正製造基準（GMP）の遵守や無菌性試験など、非経口製剤の製造に関する厳しい規制要件により、品質管理や施設のアップグレードに多額の投資が必要となります。無菌処理、特殊な保管条件、コールドチェーン・ロジスティクスに関連する高い製造コストは、市場の価格圧力にさらに拍車をかけています。こうした課題に対処するためには、製薬企業は多様なサプライチェーン、継続的製造技術、包装ソリューションの改善に投資し、市場の回復力と効率を高める必要があります。

小容量非経口薬市場の成長を促すものは何か？主な拡大要因と業界動向の特定

小容量非経口薬市場の成長は、慢性疾患や感染症の流行、生物学的製剤に対する需要の高まり、注射薬デリバリーシステムの進歩など、いくつかの要因によってもたらされます。予防接種プログラムの世界の拡大や緊急治療薬の必要性が、特にワクチンや重症患者向けセグメントでSVPの需要を大幅に押し上げています。さらに、装着型注射器や自動注射器などの自己投与デバイスの台頭により、患者の注射療法へのアドヒアランスが向上し、SVPの市場ポテンシャルが拡大しています。バイオシミラーや個別化医療の採用が増加していることも、精密で管理された非経口製剤の必要性をさらに高めています。医薬品の技術革新が薬剤の安定性、無菌性、投与の利便性を高め続けていることから、小容量非経口薬市場は持続的な成長が見込まれ、注射剤治療薬の将来において極めて重要な役割を果たしています。

セグメント

剤形（液体、ドライ）;投与量タイプ（単回投与、複数回投与）;包装タイプ（アンプル、バイアル、プレフィルドシリンジ、カートリッジ、ボトル、その他）;適応症タイプ（疼痛管理、がん治療、栄養不良、胃腸障害/下痢、糖尿病、その他）

調査対象企業の例

  • AbbVie Contract Manufacturing
  • Akums Drugs & Pharmaceuticals Ltd.
  • Alcami Corporation
  • Alembic Pharmaceuticals Ltd.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Bell-More Labs, Inc.
  • Biocon Limited
  • Bio-Concept Laboratories Inc.
  • Catalent, Inc.
  • Chemic Laboratories, Inc.
  • DSM Pharmaceuticals Inc.
  • Evonik Industries AG
  • Fresenius Kabi AG
  • Grifols Partnership
  • Hikma Pharmaceuticals PLC
  • ICU Medical, Inc.
  • KP Pharmaceutical Technology Inc.
  • Lupin Limited
  • Patheon（Thermo Fisher Scientific）
  • Pfizer Inc.
  • Renaissance Lakewood LLC
  • Sichuan Kelun Pharmaceutical Co., Ltd.
  • Singota Solutions
  • SL Pharma Labs Inc.
  • Stevanato Group
  • Torrent Pharmaceuticals Ltd.
  • Wockhardt Ltd.
  • Zydus Cadila

AIインテグレーション

私たちは、検証された専門家のコンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家からキュレートされたコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP32966

Global Small Volume Parenteral Market to Reach US$277.5 Billion by 2030

The global market for Small Volume Parenteral estimated at US$188.4 Billion in the year 2024, is expected to reach US$277.5 Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2024-2030. Liquid, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$192.0 Billion by the end of the analysis period. Growth in the Dry segment is estimated at 4.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$51.3 Billion While China is Forecast to Grow at 10.7% CAGR

The Small Volume Parenteral market in the U.S. is estimated at US$51.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$58.1 Billion by the year 2030 trailing a CAGR of 10.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.2% and 6.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.

Global Small Volume Parenteral Market - Key Trends & Drivers Summarized

Why Is the Demand for Small Volume Parenteral Increasing? Understanding Their Role in Injectable Drug Delivery

Small volume parenteral (SVP) formulations play a crucial role in modern medicine, offering efficient and controlled drug delivery for a wide range of therapeutic applications. These injectable formulations, typically packaged in vials, ampoules, or prefilled syringes, are used for critical treatments such as vaccines, biologics, antibiotics, and pain management medications. The growing prevalence of chronic diseases, such as diabetes, cardiovascular conditions, and autoimmune disorders, has significantly increased the demand for SVPs, as many of these conditions require regular injectable treatments. Additionally, advancements in biologic drug development, including monoclonal antibodies and cell therapies, have further expanded the use of SVPs in personalized medicine. With healthcare providers emphasizing faster drug absorption and targeted therapy, the adoption of small volume parenteral solutions continues to rise in hospitals, clinics, and home healthcare settings.

How Are Technological Innovations Transforming Small Volume Parenteral Manufacturing? Exploring Advancements in Aseptic Processing and Drug Stability

The manufacturing of small volume parenteral solutions has evolved with technological advancements in aseptic processing, packaging, and drug stability. Innovations in fill-finish technology, including closed-system aseptic filling, have improved sterility assurance while reducing contamination risks. Additionally, the use of advanced packaging materials, such as glass alternatives and polymer-based containers, has enhanced drug stability and shelf life. The rise of prefilled syringes and autoinjectors has further improved patient convenience, reducing the need for manual drug preparation and minimizing administration errors. AI-driven quality control systems and real-time monitoring technologies have also optimized production efficiency, ensuring regulatory compliance and product consistency. As pharmaceutical companies continue to invest in automation and smart manufacturing, the small volume parenteral market is witnessing improvements in cost-effectiveness, scalability, and safety.

What Challenges Are Affecting the Small Volume Parenteral Market? Addressing Supply Chain Constraints, Regulatory Compliance, and Production Costs

Despite the growing demand for small volume parenteral formulations, the market faces challenges related to supply chain disruptions, regulatory hurdles, and high production costs. The pharmaceutical supply chain has been impacted by raw material shortages, particularly for glass vials, sterile injectables, and specialized excipients. Additionally, stringent regulatory requirements for parenteral manufacturing, including compliance with Good Manufacturing Practices (GMP) and sterility testing, require significant investment in quality control and facility upgrades. High production costs associated with aseptic processing, specialized storage conditions, and cold chain logistics further contribute to pricing pressures in the market. Addressing these challenges requires pharmaceutical companies to invest in diversified supply chains, continuous manufacturing technologies, and improved packaging solutions to enhance market resilience and efficiency.

What’s Driving the Growth of the Small Volume Parenteral Market? Identifying Key Expansion Factors and Industry Trends

The growth in the small volume parenteral market is driven by several factors, including the increasing prevalence of chronic and infectious diseases, rising demand for biologic drugs, and advancements in injectable drug delivery systems. The global expansion of immunization programs and the need for emergency medications have significantly boosted demand for SVPs, particularly in the vaccine and critical care segments. Additionally, the rise of self-administration devices, such as wearable injectors and autoinjectors, has improved patient adherence to injectable therapies, expanding the market potential for SVPs. The increasing adoption of biosimilars and personalized medicine has further fueled the need for precise and controlled parenteral formulations. As pharmaceutical innovations continue to enhance drug stability, sterility, and administration convenience, the small volume parenteral market is expected to experience sustained growth, playing a pivotal role in the future of injectable therapeutics.

SCOPE OF STUDY:

The report analyzes the Small Volume Parenteral market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Form (Liquid, Dry); Dose Type (Single-dose, Multiple-dose); Packaging Type (Ampoules, Vials, Pre-filled Syringes, Cartridges, Bottles, Others); Indication Type (Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • AbbVie Contract Manufacturing
  • Akums Drugs & Pharmaceuticals Ltd.
  • Alcami Corporation
  • Alembic Pharmaceuticals Ltd.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Bell-More Labs, Inc.
  • Biocon Limited
  • Bio-Concept Laboratories Inc.
  • Catalent, Inc.
  • Chemic Laboratories, Inc.
  • DSM Pharmaceuticals Inc.
  • Evonik Industries AG
  • Fresenius Kabi AG
  • Grifols Partnership
  • Hikma Pharmaceuticals PLC
  • ICU Medical, Inc.
  • KP Pharmaceutical Technology Inc.
  • Lupin Limited
  • Patheon (Thermo Fisher Scientific)
  • Pfizer Inc.
  • Renaissance Lakewood LLC
  • Sichuan Kelun Pharmaceutical Co., Ltd.
  • Singota Solutions
  • SL Pharma Labs Inc.
  • Stevanato Group
  • Torrent Pharmaceuticals Ltd.
  • Wockhardt Ltd.
  • Zydus Cadila

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Small Volume Parenteral - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Targeted Therapeutics and Biologics Throws the Spotlight on Small Volume Parenteral Formulations
    • Growth in Chronic Disease Management and Specialty Drug Delivery Drives Adoption of SVP Presentations
    • OEM Innovation in Ready-to-Inject Formats and Pre-Filled Syringes Enhances Administration Efficiency
    • Expansion of Biosimilars and Injectables in Oncology and Rheumatology Spurs Market Penetration
    • OEM Development of Advanced Aseptic Fill-Finish Platforms Strengthens Quality and Sterility Assurance
    • Increasing Focus on Home Healthcare and Self-Administration Propels Demand for Compact Injectable Doses
    • OEM Investment in Blow-Fill-Seal and Nested Syringe Technology Enhances Scalability of SVP Manufacturing
    • Surging Need for Controlled Dosage and Reduced Wastage Supports Shift From Vials to Unit-Dose SVPs
    • OEM Emphasis on 503B Outsourcing and Compounded Injectables Expands Supply to Hospital Pharmacies
    • Growth in Clinical Trials and Phase I/II Programs Drives Batch Flexibility and Rapid Turnaround in SVP Production
    • OEM Collaboration With Biotech Innovators and CDMOs Promotes End-to-End Injectable Development
    • Rising Preference for Subcutaneous and Intramuscular Routes in Non-Hospital Settings Supports Volume Optimization
    • OEM Focus on Regulatory Compliance With Annex 1 and USP <800> Enhances Market Access Across Geographies
    • Expansion of Wearable Drug Delivery Devices and On-Body Injectors Drives Integration With SVP Formats
    • OEM Innovation in Silicone-Free, Low Particulate Packaging Boosts Biologic Stability and Safety
    • Growth in High-Value Therapies and Precision Medicine Supports Custom Fill-Volume Formulations
    • OEM Strategies to Reduce Extractables and Leachables in Contact Materials Strengthen Compatibility Metrics
    • Increasing Demand for Temperature-Stable, Lyophilized SVPs Spurs Cold Chain Cost Optimization
    • OEM Emphasis on Automation and Robotics in SVP Fill-Finish Enhances Operational Throughput
    • Focus on Lifecycle Management, Line Extensions, and Dual-Chamber Systems Sustains Brand Value Post-Patent
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Small Volume Parenteral Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Small Volume Parenteral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Small Volume Parenteral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Small Volume Parenteral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Liquid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Liquid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Liquid by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Dry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Dry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Dry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other Packaging Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other Packaging Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Other Packaging Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Ampoules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Ampoules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Ampoules by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Vials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Vials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Vials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Pre-filled Syringes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Pre-filled Syringes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Pre-filled Syringes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Cartridges by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Cartridges by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Cartridges by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Bottles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Bottles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Bottles by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Pain Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Pain Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Pain Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Cancer Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Cancer Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Cancer Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Malnourishment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Malnourishment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Malnourishment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Gastrointestinal disorder / Diarrhea by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Gastrointestinal disorder / Diarrhea by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Gastrointestinal disorder / Diarrhea by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: World 15-Year Perspective for Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: World 15-Year Perspective for Other Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 47: World Recent Past, Current & Future Analysis for Single-dose by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 48: World Historic Review for Single-dose by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: World 15-Year Perspective for Single-dose by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 50: World Recent Past, Current & Future Analysis for Multiple-dose by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 51: World Historic Review for Multiple-dose by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: World 15-Year Perspective for Multiple-dose by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Small Volume Parenteral Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 53: USA Recent Past, Current & Future Analysis for Small Volume Parenteral by Form - Liquid and Dry - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: USA Historic Review for Small Volume Parenteral by Form - Liquid and Dry Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: USA 15-Year Perspective for Small Volume Parenteral by Form - Percentage Breakdown of Value Sales for Liquid and Dry for the Years 2015, 2025 & 2030
    • TABLE 56: USA Recent Past, Current & Future Analysis for Small Volume Parenteral by Packaging Type - Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: USA Historic Review for Small Volume Parenteral by Packaging Type - Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: USA 15-Year Perspective for Small Volume Parenteral by Packaging Type - Percentage Breakdown of Value Sales for Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles for the Years 2015, 2025 & 2030
    • TABLE 59: USA Recent Past, Current & Future Analysis for Small Volume Parenteral by Indication Type - Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: USA Historic Review for Small Volume Parenteral by Indication Type - Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: USA 15-Year Perspective for Small Volume Parenteral by Indication Type - Percentage Breakdown of Value Sales for Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 62: USA Recent Past, Current & Future Analysis for Small Volume Parenteral by Dose Type - Single-dose and Multiple-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: USA Historic Review for Small Volume Parenteral by Dose Type - Single-dose and Multiple-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: USA 15-Year Perspective for Small Volume Parenteral by Dose Type - Percentage Breakdown of Value Sales for Single-dose and Multiple-dose for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 65: Canada Recent Past, Current & Future Analysis for Small Volume Parenteral by Form - Liquid and Dry - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Canada Historic Review for Small Volume Parenteral by Form - Liquid and Dry Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Canada 15-Year Perspective for Small Volume Parenteral by Form - Percentage Breakdown of Value Sales for Liquid and Dry for the Years 2015, 2025 & 2030
    • TABLE 68: Canada Recent Past, Current & Future Analysis for Small Volume Parenteral by Packaging Type - Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Canada Historic Review for Small Volume Parenteral by Packaging Type - Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Canada 15-Year Perspective for Small Volume Parenteral by Packaging Type - Percentage Breakdown of Value Sales for Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles for the Years 2015, 2025 & 2030
    • TABLE 71: Canada Recent Past, Current & Future Analysis for Small Volume Parenteral by Indication Type - Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Canada Historic Review for Small Volume Parenteral by Indication Type - Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Canada 15-Year Perspective for Small Volume Parenteral by Indication Type - Percentage Breakdown of Value Sales for Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 74: Canada Recent Past, Current & Future Analysis for Small Volume Parenteral by Dose Type - Single-dose and Multiple-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Canada Historic Review for Small Volume Parenteral by Dose Type - Single-dose and Multiple-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Canada 15-Year Perspective for Small Volume Parenteral by Dose Type - Percentage Breakdown of Value Sales for Single-dose and Multiple-dose for the Years 2015, 2025 & 2030
  • JAPAN
    • Small Volume Parenteral Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 77: Japan Recent Past, Current & Future Analysis for Small Volume Parenteral by Form - Liquid and Dry - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Japan Historic Review for Small Volume Parenteral by Form - Liquid and Dry Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Japan 15-Year Perspective for Small Volume Parenteral by Form - Percentage Breakdown of Value Sales for Liquid and Dry for the Years 2015, 2025 & 2030
    • TABLE 80: Japan Recent Past, Current & Future Analysis for Small Volume Parenteral by Packaging Type - Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Japan Historic Review for Small Volume Parenteral by Packaging Type - Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Japan 15-Year Perspective for Small Volume Parenteral by Packaging Type - Percentage Breakdown of Value Sales for Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles for the Years 2015, 2025 & 2030
    • TABLE 83: Japan Recent Past, Current & Future Analysis for Small Volume Parenteral by Indication Type - Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Japan Historic Review for Small Volume Parenteral by Indication Type - Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Japan 15-Year Perspective for Small Volume Parenteral by Indication Type - Percentage Breakdown of Value Sales for Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 86: Japan Recent Past, Current & Future Analysis for Small Volume Parenteral by Dose Type - Single-dose and Multiple-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Japan Historic Review for Small Volume Parenteral by Dose Type - Single-dose and Multiple-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Japan 15-Year Perspective for Small Volume Parenteral by Dose Type - Percentage Breakdown of Value Sales for Single-dose and Multiple-dose for the Years 2015, 2025 & 2030
  • CHINA
    • Small Volume Parenteral Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 89: China Recent Past, Current & Future Analysis for Small Volume Parenteral by Form - Liquid and Dry - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: China Historic Review for Small Volume Parenteral by Form - Liquid and Dry Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: China 15-Year Perspective for Small Volume Parenteral by Form - Percentage Breakdown of Value Sales for Liquid and Dry for the Years 2015, 2025 & 2030
    • TABLE 92: China Recent Past, Current & Future Analysis for Small Volume Parenteral by Packaging Type - Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: China Historic Review for Small Volume Parenteral by Packaging Type - Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: China 15-Year Perspective for Small Volume Parenteral by Packaging Type - Percentage Breakdown of Value Sales for Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles for the Years 2015, 2025 & 2030
    • TABLE 95: China Recent Past, Current & Future Analysis for Small Volume Parenteral by Indication Type - Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: China Historic Review for Small Volume Parenteral by Indication Type - Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: China 15-Year Perspective for Small Volume Parenteral by Indication Type - Percentage Breakdown of Value Sales for Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 98: China Recent Past, Current & Future Analysis for Small Volume Parenteral by Dose Type - Single-dose and Multiple-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: China Historic Review for Small Volume Parenteral by Dose Type - Single-dose and Multiple-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: China 15-Year Perspective for Small Volume Parenteral by Dose Type - Percentage Breakdown of Value Sales for Single-dose and Multiple-dose for the Years 2015, 2025 & 2030
  • EUROPE
    • Small Volume Parenteral Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 101: Europe Recent Past, Current & Future Analysis for Small Volume Parenteral by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 102: Europe Historic Review for Small Volume Parenteral by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Europe 15-Year Perspective for Small Volume Parenteral by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 104: Europe Recent Past, Current & Future Analysis for Small Volume Parenteral by Form - Liquid and Dry - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Europe Historic Review for Small Volume Parenteral by Form - Liquid and Dry Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Europe 15-Year Perspective for Small Volume Parenteral by Form - Percentage Breakdown of Value Sales for Liquid and Dry for the Years 2015, 2025 & 2030
    • TABLE 107: Europe Recent Past, Current & Future Analysis for Small Volume Parenteral by Packaging Type - Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Europe Historic Review for Small Volume Parenteral by Packaging Type - Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Europe 15-Year Perspective for Small Volume Parenteral by Packaging Type - Percentage Breakdown of Value Sales for Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles for the Years 2015, 2025 & 2030
    • TABLE 110: Europe Recent Past, Current & Future Analysis for Small Volume Parenteral by Indication Type - Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Europe Historic Review for Small Volume Parenteral by Indication Type - Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Europe 15-Year Perspective for Small Volume Parenteral by Indication Type - Percentage Breakdown of Value Sales for Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 113: Europe Recent Past, Current & Future Analysis for Small Volume Parenteral by Dose Type - Single-dose and Multiple-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Europe Historic Review for Small Volume Parenteral by Dose Type - Single-dose and Multiple-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Europe 15-Year Perspective for Small Volume Parenteral by Dose Type - Percentage Breakdown of Value Sales for Single-dose and Multiple-dose for the Years 2015, 2025 & 2030
  • FRANCE
    • Small Volume Parenteral Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 116: France Recent Past, Current & Future Analysis for Small Volume Parenteral by Form - Liquid and Dry - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: France Historic Review for Small Volume Parenteral by Form - Liquid and Dry Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: France 15-Year Perspective for Small Volume Parenteral by Form - Percentage Breakdown of Value Sales for Liquid and Dry for the Years 2015, 2025 & 2030
    • TABLE 119: France Recent Past, Current & Future Analysis for Small Volume Parenteral by Packaging Type - Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: France Historic Review for Small Volume Parenteral by Packaging Type - Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: France 15-Year Perspective for Small Volume Parenteral by Packaging Type - Percentage Breakdown of Value Sales for Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles for the Years 2015, 2025 & 2030
    • TABLE 122: France Recent Past, Current & Future Analysis for Small Volume Parenteral by Indication Type - Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: France Historic Review for Small Volume Parenteral by Indication Type - Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: France 15-Year Perspective for Small Volume Parenteral by Indication Type - Percentage Breakdown of Value Sales for Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 125: France Recent Past, Current & Future Analysis for Small Volume Parenteral by Dose Type - Single-dose and Multiple-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: France Historic Review for Small Volume Parenteral by Dose Type - Single-dose and Multiple-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: France 15-Year Perspective for Small Volume Parenteral by Dose Type - Percentage Breakdown of Value Sales for Single-dose and Multiple-dose for the Years 2015, 2025 & 2030
  • GERMANY
    • Small Volume Parenteral Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 128: Germany Recent Past, Current & Future Analysis for Small Volume Parenteral by Form - Liquid and Dry - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Germany Historic Review for Small Volume Parenteral by Form - Liquid and Dry Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Germany 15-Year Perspective for Small Volume Parenteral by Form - Percentage Breakdown of Value Sales for Liquid and Dry for the Years 2015, 2025 & 2030
    • TABLE 131: Germany Recent Past, Current & Future Analysis for Small Volume Parenteral by Packaging Type - Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Germany Historic Review for Small Volume Parenteral by Packaging Type - Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Germany 15-Year Perspective for Small Volume Parenteral by Packaging Type - Percentage Breakdown of Value Sales for Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles for the Years 2015, 2025 & 2030
    • TABLE 134: Germany Recent Past, Current & Future Analysis for Small Volume Parenteral by Indication Type - Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Germany Historic Review for Small Volume Parenteral by Indication Type - Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Germany 15-Year Perspective for Small Volume Parenteral by Indication Type - Percentage Breakdown of Value Sales for Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 137: Germany Recent Past, Current & Future Analysis for Small Volume Parenteral by Dose Type - Single-dose and Multiple-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Germany Historic Review for Small Volume Parenteral by Dose Type - Single-dose and Multiple-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Germany 15-Year Perspective for Small Volume Parenteral by Dose Type - Percentage Breakdown of Value Sales for Single-dose and Multiple-dose for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 140: Italy Recent Past, Current & Future Analysis for Small Volume Parenteral by Form - Liquid and Dry - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Italy Historic Review for Small Volume Parenteral by Form - Liquid and Dry Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Italy 15-Year Perspective for Small Volume Parenteral by Form - Percentage Breakdown of Value Sales for Liquid and Dry for the Years 2015, 2025 & 2030
    • TABLE 143: Italy Recent Past, Current & Future Analysis for Small Volume Parenteral by Packaging Type - Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Italy Historic Review for Small Volume Parenteral by Packaging Type - Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Italy 15-Year Perspective for Small Volume Parenteral by Packaging Type - Percentage Breakdown of Value Sales for Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles for the Years 2015, 2025 & 2030
    • TABLE 146: Italy Recent Past, Current & Future Analysis for Small Volume Parenteral by Indication Type - Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Italy Historic Review for Small Volume Parenteral by Indication Type - Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Italy 15-Year Perspective for Small Volume Parenteral by Indication Type - Percentage Breakdown of Value Sales for Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 149: Italy Recent Past, Current & Future Analysis for Small Volume Parenteral by Dose Type - Single-dose and Multiple-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Italy Historic Review for Small Volume Parenteral by Dose Type - Single-dose and Multiple-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Italy 15-Year Perspective for Small Volume Parenteral by Dose Type - Percentage Breakdown of Value Sales for Single-dose and Multiple-dose for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Small Volume Parenteral Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 152: UK Recent Past, Current & Future Analysis for Small Volume Parenteral by Form - Liquid and Dry - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: UK Historic Review for Small Volume Parenteral by Form - Liquid and Dry Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: UK 15-Year Perspective for Small Volume Parenteral by Form - Percentage Breakdown of Value Sales for Liquid and Dry for the Years 2015, 2025 & 2030
    • TABLE 155: UK Recent Past, Current & Future Analysis for Small Volume Parenteral by Packaging Type - Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: UK Historic Review for Small Volume Parenteral by Packaging Type - Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: UK 15-Year Perspective for Small Volume Parenteral by Packaging Type - Percentage Breakdown of Value Sales for Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles for the Years 2015, 2025 & 2030
    • TABLE 158: UK Recent Past, Current & Future Analysis for Small Volume Parenteral by Indication Type - Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: UK Historic Review for Small Volume Parenteral by Indication Type - Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: UK 15-Year Perspective for Small Volume Parenteral by Indication Type - Percentage Breakdown of Value Sales for Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 161: UK Recent Past, Current & Future Analysis for Small Volume Parenteral by Dose Type - Single-dose and Multiple-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: UK Historic Review for Small Volume Parenteral by Dose Type - Single-dose and Multiple-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: UK 15-Year Perspective for Small Volume Parenteral by Dose Type - Percentage Breakdown of Value Sales for Single-dose and Multiple-dose for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 164: Spain Recent Past, Current & Future Analysis for Small Volume Parenteral by Form - Liquid and Dry - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Spain Historic Review for Small Volume Parenteral by Form - Liquid and Dry Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Spain 15-Year Perspective for Small Volume Parenteral by Form - Percentage Breakdown of Value Sales for Liquid and Dry for the Years 2015, 2025 & 2030
    • TABLE 167: Spain Recent Past, Current & Future Analysis for Small Volume Parenteral by Packaging Type - Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Spain Historic Review for Small Volume Parenteral by Packaging Type - Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Spain 15-Year Perspective for Small Volume Parenteral by Packaging Type - Percentage Breakdown of Value Sales for Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles for the Years 2015, 2025 & 2030
    • TABLE 170: Spain Recent Past, Current & Future Analysis for Small Volume Parenteral by Indication Type - Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Spain Historic Review for Small Volume Parenteral by Indication Type - Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Spain 15-Year Perspective for Small Volume Parenteral by Indication Type - Percentage Breakdown of Value Sales for Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 173: Spain Recent Past, Current & Future Analysis for Small Volume Parenteral by Dose Type - Single-dose and Multiple-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Spain Historic Review for Small Volume Parenteral by Dose Type - Single-dose and Multiple-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Spain 15-Year Perspective for Small Volume Parenteral by Dose Type - Percentage Breakdown of Value Sales for Single-dose and Multiple-dose for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 176: Russia Recent Past, Current & Future Analysis for Small Volume Parenteral by Form - Liquid and Dry - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Russia Historic Review for Small Volume Parenteral by Form - Liquid and Dry Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Russia 15-Year Perspective for Small Volume Parenteral by Form - Percentage Breakdown of Value Sales for Liquid and Dry for the Years 2015, 2025 & 2030
    • TABLE 179: Russia Recent Past, Current & Future Analysis for Small Volume Parenteral by Packaging Type - Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Russia Historic Review for Small Volume Parenteral by Packaging Type - Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Russia 15-Year Perspective for Small Volume Parenteral by Packaging Type - Percentage Breakdown of Value Sales for Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles for the Years 2015, 2025 & 2030
    • TABLE 182: Russia Recent Past, Current & Future Analysis for Small Volume Parenteral by Indication Type - Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Russia Historic Review for Small Volume Parenteral by Indication Type - Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Russia 15-Year Perspective for Small Volume Parenteral by Indication Type - Percentage Breakdown of Value Sales for Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 185: Russia Recent Past, Current & Future Analysis for Small Volume Parenteral by Dose Type - Single-dose and Multiple-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Russia Historic Review for Small Volume Parenteral by Dose Type - Single-dose and Multiple-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Russia 15-Year Perspective for Small Volume Parenteral by Dose Type - Percentage Breakdown of Value Sales for Single-dose and Multiple-dose for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 188: Rest of Europe Recent Past, Current & Future Analysis for Small Volume Parenteral by Form - Liquid and Dry - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Europe Historic Review for Small Volume Parenteral by Form - Liquid and Dry Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Europe 15-Year Perspective for Small Volume Parenteral by Form - Percentage Breakdown of Value Sales for Liquid and Dry for the Years 2015, 2025 & 2030
    • TABLE 191: Rest of Europe Recent Past, Current & Future Analysis for Small Volume Parenteral by Packaging Type - Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Europe Historic Review for Small Volume Parenteral by Packaging Type - Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Europe 15-Year Perspective for Small Volume Parenteral by Packaging Type - Percentage Breakdown of Value Sales for Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles for the Years 2015, 2025 & 2030
    • TABLE 194: Rest of Europe Recent Past, Current & Future Analysis for Small Volume Parenteral by Indication Type - Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Europe Historic Review for Small Volume Parenteral by Indication Type - Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Europe 15-Year Perspective for Small Volume Parenteral by Indication Type - Percentage Breakdown of Value Sales for Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 197: Rest of Europe Recent Past, Current & Future Analysis for Small Volume Parenteral by Dose Type - Single-dose and Multiple-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Europe Historic Review for Small Volume Parenteral by Dose Type - Single-dose and Multiple-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Europe 15-Year Perspective for Small Volume Parenteral by Dose Type - Percentage Breakdown of Value Sales for Single-dose and Multiple-dose for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Small Volume Parenteral Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 200: Asia-Pacific Recent Past, Current & Future Analysis for Small Volume Parenteral by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 201: Asia-Pacific Historic Review for Small Volume Parenteral by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Asia-Pacific 15-Year Perspective for Small Volume Parenteral by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 203: Asia-Pacific Recent Past, Current & Future Analysis for Small Volume Parenteral by Form - Liquid and Dry - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Asia-Pacific Historic Review for Small Volume Parenteral by Form - Liquid and Dry Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Asia-Pacific 15-Year Perspective for Small Volume Parenteral by Form - Percentage Breakdown of Value Sales for Liquid and Dry for the Years 2015, 2025 & 2030
    • TABLE 206: Asia-Pacific Recent Past, Current & Future Analysis for Small Volume Parenteral by Packaging Type - Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Asia-Pacific Historic Review for Small Volume Parenteral by Packaging Type - Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Asia-Pacific 15-Year Perspective for Small Volume Parenteral by Packaging Type - Percentage Breakdown of Value Sales for Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles for the Years 2015, 2025 & 2030
    • TABLE 209: Asia-Pacific Recent Past, Current & Future Analysis for Small Volume Parenteral by Indication Type - Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Asia-Pacific Historic Review for Small Volume Parenteral by Indication Type - Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Asia-Pacific 15-Year Perspective for Small Volume Parenteral by Indication Type - Percentage Breakdown of Value Sales for Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 212: Asia-Pacific Recent Past, Current & Future Analysis for Small Volume Parenteral by Dose Type - Single-dose and Multiple-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Asia-Pacific Historic Review for Small Volume Parenteral by Dose Type - Single-dose and Multiple-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Asia-Pacific 15-Year Perspective for Small Volume Parenteral by Dose Type - Percentage Breakdown of Value Sales for Single-dose and Multiple-dose for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Small Volume Parenteral Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 215: Australia Recent Past, Current & Future Analysis for Small Volume Parenteral by Form - Liquid and Dry - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Australia Historic Review for Small Volume Parenteral by Form - Liquid and Dry Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Australia 15-Year Perspective for Small Volume Parenteral by Form - Percentage Breakdown of Value Sales for Liquid and Dry for the Years 2015, 2025 & 2030
    • TABLE 218: Australia Recent Past, Current & Future Analysis for Small Volume Parenteral by Packaging Type - Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Australia Historic Review for Small Volume Parenteral by Packaging Type - Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Australia 15-Year Perspective for Small Volume Parenteral by Packaging Type - Percentage Breakdown of Value Sales for Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles for the Years 2015, 2025 & 2030
    • TABLE 221: Australia Recent Past, Current & Future Analysis for Small Volume Parenteral by Indication Type - Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Australia Historic Review for Small Volume Parenteral by Indication Type - Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Australia 15-Year Perspective for Small Volume Parenteral by Indication Type - Percentage Breakdown of Value Sales for Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 224: Australia Recent Past, Current & Future Analysis for Small Volume Parenteral by Dose Type - Single-dose and Multiple-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Australia Historic Review for Small Volume Parenteral by Dose Type - Single-dose and Multiple-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Australia 15-Year Perspective for Small Volume Parenteral by Dose Type - Percentage Breakdown of Value Sales for Single-dose and Multiple-dose for the Years 2015, 2025 & 2030
  • INDIA
    • Small Volume Parenteral Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 227: India Recent Past, Current & Future Analysis for Small Volume Parenteral by Form - Liquid and Dry - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: India Historic Review for Small Volume Parenteral by Form - Liquid and Dry Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: India 15-Year Perspective for Small Volume Parenteral by Form - Percentage Breakdown of Value Sales for Liquid and Dry for the Years 2015, 2025 & 2030
    • TABLE 230: India Recent Past, Current & Future Analysis for Small Volume Parenteral by Packaging Type - Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: India Historic Review for Small Volume Parenteral by Packaging Type - Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: India 15-Year Perspective for Small Volume Parenteral by Packaging Type - Percentage Breakdown of Value Sales for Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles for the Years 2015, 2025 & 2030
    • TABLE 233: India Recent Past, Current & Future Analysis for Small Volume Parenteral by Indication Type - Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: India Historic Review for Small Volume Parenteral by Indication Type - Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: India 15-Year Perspective for Small Volume Parenteral by Indication Type - Percentage Breakdown of Value Sales for Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 236: India Recent Past, Current & Future Analysis for Small Volume Parenteral by Dose Type - Single-dose and Multiple-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: India Historic Review for Small Volume Parenteral by Dose Type - Single-dose and Multiple-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: India 15-Year Perspective for Small Volume Parenteral by Dose Type - Percentage Breakdown of Value Sales for Single-dose and Multiple-dose for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 239: South Korea Recent Past, Current & Future Analysis for Small Volume Parenteral by Form - Liquid and Dry - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: South Korea Historic Review for Small Volume Parenteral by Form - Liquid and Dry Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: South Korea 15-Year Perspective for Small Volume Parenteral by Form - Percentage Breakdown of Value Sales for Liquid and Dry for the Years 2015, 2025 & 2030
    • TABLE 242: South Korea Recent Past, Current & Future Analysis for Small Volume Parenteral by Packaging Type - Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: South Korea Historic Review for Small Volume Parenteral by Packaging Type - Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: South Korea 15-Year Perspective for Small Volume Parenteral by Packaging Type - Percentage Breakdown of Value Sales for Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles for the Years 2015, 2025 & 2030
    • TABLE 245: South Korea Recent Past, Current & Future Analysis for Small Volume Parenteral by Indication Type - Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: South Korea Historic Review for Small Volume Parenteral by Indication Type - Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: South Korea 15-Year Perspective for Small Volume Parenteral by Indication Type - Percentage Breakdown of Value Sales for Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 248: South Korea Recent Past, Current & Future Analysis for Small Volume Parenteral by Dose Type - Single-dose and Multiple-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: South Korea Historic Review for Small Volume Parenteral by Dose Type - Single-dose and Multiple-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: South Korea 15-Year Perspective for Small Volume Parenteral by Dose Type - Percentage Breakdown of Value Sales for Single-dose and Multiple-dose for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 251: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Small Volume Parenteral by Form - Liquid and Dry - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Rest of Asia-Pacific Historic Review for Small Volume Parenteral by Form - Liquid and Dry Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Rest of Asia-Pacific 15-Year Perspective for Small Volume Parenteral by Form - Percentage Breakdown of Value Sales for Liquid and Dry for the Years 2015, 2025 & 2030
    • TABLE 254: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Small Volume Parenteral by Packaging Type - Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Rest of Asia-Pacific Historic Review for Small Volume Parenteral by Packaging Type - Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Rest of Asia-Pacific 15-Year Perspective for Small Volume Parenteral by Packaging Type - Percentage Breakdown of Value Sales for Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles for the Years 2015, 2025 & 2030
    • TABLE 257: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Small Volume Parenteral by Indication Type - Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Rest of Asia-Pacific Historic Review for Small Volume Parenteral by Indication Type - Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Rest of Asia-Pacific 15-Year Perspective for Small Volume Parenteral by Indication Type - Percentage Breakdown of Value Sales for Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 260: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Small Volume Parenteral by Dose Type - Single-dose and Multiple-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Rest of Asia-Pacific Historic Review for Small Volume Parenteral by Dose Type - Single-dose and Multiple-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Rest of Asia-Pacific 15-Year Perspective for Small Volume Parenteral by Dose Type - Percentage Breakdown of Value Sales for Single-dose and Multiple-dose for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Small Volume Parenteral Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 263: Latin America Recent Past, Current & Future Analysis for Small Volume Parenteral by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 264: Latin America Historic Review for Small Volume Parenteral by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Latin America 15-Year Perspective for Small Volume Parenteral by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 266: Latin America Recent Past, Current & Future Analysis for Small Volume Parenteral by Form - Liquid and Dry - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Latin America Historic Review for Small Volume Parenteral by Form - Liquid and Dry Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Latin America 15-Year Perspective for Small Volume Parenteral by Form - Percentage Breakdown of Value Sales for Liquid and Dry for the Years 2015, 2025 & 2030
    • TABLE 269: Latin America Recent Past, Current & Future Analysis for Small Volume Parenteral by Packaging Type - Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Latin America Historic Review for Small Volume Parenteral by Packaging Type - Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Latin America 15-Year Perspective for Small Volume Parenteral by Packaging Type - Percentage Breakdown of Value Sales for Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles for the Years 2015, 2025 & 2030
    • TABLE 272: Latin America Recent Past, Current & Future Analysis for Small Volume Parenteral by Indication Type - Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Latin America Historic Review for Small Volume Parenteral by Indication Type - Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: Latin America 15-Year Perspective for Small Volume Parenteral by Indication Type - Percentage Breakdown of Value Sales for Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 275: Latin America Recent Past, Current & Future Analysis for Small Volume Parenteral by Dose Type - Single-dose and Multiple-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Latin America Historic Review for Small Volume Parenteral by Dose Type - Single-dose and Multiple-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: Latin America 15-Year Perspective for Small Volume Parenteral by Dose Type - Percentage Breakdown of Value Sales for Single-dose and Multiple-dose for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 278: Argentina Recent Past, Current & Future Analysis for Small Volume Parenteral by Form - Liquid and Dry - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Argentina Historic Review for Small Volume Parenteral by Form - Liquid and Dry Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: Argentina 15-Year Perspective for Small Volume Parenteral by Form - Percentage Breakdown of Value Sales for Liquid and Dry for the Years 2015, 2025 & 2030
    • TABLE 281: Argentina Recent Past, Current & Future Analysis for Small Volume Parenteral by Packaging Type - Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Argentina Historic Review for Small Volume Parenteral by Packaging Type - Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: Argentina 15-Year Perspective for Small Volume Parenteral by Packaging Type - Percentage Breakdown of Value Sales for Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles for the Years 2015, 2025 & 2030
    • TABLE 284: Argentina Recent Past, Current & Future Analysis for Small Volume Parenteral by Indication Type - Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Argentina Historic Review for Small Volume Parenteral by Indication Type - Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: Argentina 15-Year Perspective for Small Volume Parenteral by Indication Type - Percentage Breakdown of Value Sales for Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 287: Argentina Recent Past, Current & Future Analysis for Small Volume Parenteral by Dose Type - Single-dose and Multiple-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Argentina Historic Review for Small Volume Parenteral by Dose Type - Single-dose and Multiple-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: Argentina 15-Year Perspective for Small Volume Parenteral by Dose Type - Percentage Breakdown of Value Sales for Single-dose and Multiple-dose for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 290: Brazil Recent Past, Current & Future Analysis for Small Volume Parenteral by Form - Liquid and Dry - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Brazil Historic Review for Small Volume Parenteral by Form - Liquid and Dry Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: Brazil 15-Year Perspective for Small Volume Parenteral by Form - Percentage Breakdown of Value Sales for Liquid and Dry for the Years 2015, 2025 & 2030
    • TABLE 293: Brazil Recent Past, Current & Future Analysis for Small Volume Parenteral by Packaging Type - Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Brazil Historic Review for Small Volume Parenteral by Packaging Type - Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: Brazil 15-Year Perspective for Small Volume Parenteral by Packaging Type - Percentage Breakdown of Value Sales for Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles for the Years 2015, 2025 & 2030
    • TABLE 296: Brazil Recent Past, Current & Future Analysis for Small Volume Parenteral by Indication Type - Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Brazil Historic Review for Small Volume Parenteral by Indication Type - Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: Brazil 15-Year Perspective for Small Volume Parenteral by Indication Type - Percentage Breakdown of Value Sales for Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 299: Brazil Recent Past, Current & Future Analysis for Small Volume Parenteral by Dose Type - Single-dose and Multiple-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Brazil Historic Review for Small Volume Parenteral by Dose Type - Single-dose and Multiple-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: Brazil 15-Year Perspective for Small Volume Parenteral by Dose Type - Percentage Breakdown of Value Sales for Single-dose and Multiple-dose for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 302: Mexico Recent Past, Current & Future Analysis for Small Volume Parenteral by Form - Liquid and Dry - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Mexico Historic Review for Small Volume Parenteral by Form - Liquid and Dry Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 304: Mexico 15-Year Perspective for Small Volume Parenteral by Form - Percentage Breakdown of Value Sales for Liquid and Dry for the Years 2015, 2025 & 2030
    • TABLE 305: Mexico Recent Past, Current & Future Analysis for Small Volume Parenteral by Packaging Type - Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Mexico Historic Review for Small Volume Parenteral by Packaging Type - Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 307: Mexico 15-Year Perspective for Small Volume Parenteral by Packaging Type - Percentage Breakdown of Value Sales for Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles for the Years 2015, 2025 & 2030
    • TABLE 308: Mexico Recent Past, Current & Future Analysis for Small Volume Parenteral by Indication Type - Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Mexico Historic Review for Small Volume Parenteral by Indication Type - Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 310: Mexico 15-Year Perspective for Small Volume Parenteral by Indication Type - Percentage Breakdown of Value Sales for Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 311: Mexico Recent Past, Current & Future Analysis for Small Volume Parenteral by Dose Type - Single-dose and Multiple-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Mexico Historic Review for Small Volume Parenteral by Dose Type - Single-dose and Multiple-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 313: Mexico 15-Year Perspective for Small Volume Parenteral by Dose Type - Percentage Breakdown of Value Sales for Single-dose and Multiple-dose for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 314: Rest of Latin America Recent Past, Current & Future Analysis for Small Volume Parenteral by Form - Liquid and Dry - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Rest of Latin America Historic Review for Small Volume Parenteral by Form - Liquid and Dry Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 316: Rest of Latin America 15-Year Perspective for Small Volume Parenteral by Form - Percentage Breakdown of Value Sales for Liquid and Dry for the Years 2015, 2025 & 2030
    • TABLE 317: Rest of Latin America Recent Past, Current & Future Analysis for Small Volume Parenteral by Packaging Type - Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 318: Rest of Latin America Historic Review for Small Volume Parenteral by Packaging Type - Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 319: Rest of Latin America 15-Year Perspective for Small Volume Parenteral by Packaging Type - Percentage Breakdown of Value Sales for Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles for the Years 2015, 2025 & 2030
    • TABLE 320: Rest of Latin America Recent Past, Current & Future Analysis for Small Volume Parenteral by Indication Type - Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 321: Rest of Latin America Historic Review for Small Volume Parenteral by Indication Type - Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 322: Rest of Latin America 15-Year Perspective for Small Volume Parenteral by Indication Type - Percentage Breakdown of Value Sales for Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 323: Rest of Latin America Recent Past, Current & Future Analysis for Small Volume Parenteral by Dose Type - Single-dose and Multiple-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 324: Rest of Latin America Historic Review for Small Volume Parenteral by Dose Type - Single-dose and Multiple-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 325: Rest of Latin America 15-Year Perspective for Small Volume Parenteral by Dose Type - Percentage Breakdown of Value Sales for Single-dose and Multiple-dose for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Small Volume Parenteral Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 326: Middle East Recent Past, Current & Future Analysis for Small Volume Parenteral by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 327: Middle East Historic Review for Small Volume Parenteral by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 328: Middle East 15-Year Perspective for Small Volume Parenteral by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 329: Middle East Recent Past, Current & Future Analysis for Small Volume Parenteral by Form - Liquid and Dry - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 330: Middle East Historic Review for Small Volume Parenteral by Form - Liquid and Dry Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 331: Middle East 15-Year Perspective for Small Volume Parenteral by Form - Percentage Breakdown of Value Sales for Liquid and Dry for the Years 2015, 2025 & 2030
    • TABLE 332: Middle East Recent Past, Current & Future Analysis for Small Volume Parenteral by Packaging Type - Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 333: Middle East Historic Review for Small Volume Parenteral by Packaging Type - Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 334: Middle East 15-Year Perspective for Small Volume Parenteral by Packaging Type - Percentage Breakdown of Value Sales for Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles for the Years 2015, 2025 & 2030
    • TABLE 335: Middle East Recent Past, Current & Future Analysis for Small Volume Parenteral by Indication Type - Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 336: Middle East Historic Review for Small Volume Parenteral by Indication Type - Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 337: Middle East 15-Year Perspective for Small Volume Parenteral by Indication Type - Percentage Breakdown of Value Sales for Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 338: Middle East Recent Past, Current & Future Analysis for Small Volume Parenteral by Dose Type - Single-dose and Multiple-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 339: Middle East Historic Review for Small Volume Parenteral by Dose Type - Single-dose and Multiple-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 340: Middle East 15-Year Perspective for Small Volume Parenteral by Dose Type - Percentage Breakdown of Value Sales for Single-dose and Multiple-dose for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 341: Iran Recent Past, Current & Future Analysis for Small Volume Parenteral by Form - Liquid and Dry - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 342: Iran Historic Review for Small Volume Parenteral by Form - Liquid and Dry Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 343: Iran 15-Year Perspective for Small Volume Parenteral by Form - Percentage Breakdown of Value Sales for Liquid and Dry for the Years 2015, 2025 & 2030
    • TABLE 344: Iran Recent Past, Current & Future Analysis for Small Volume Parenteral by Packaging Type - Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 345: Iran Historic Review for Small Volume Parenteral by Packaging Type - Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 346: Iran 15-Year Perspective for Small Volume Parenteral by Packaging Type - Percentage Breakdown of Value Sales for Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles for the Years 2015, 2025 & 2030
    • TABLE 347: Iran Recent Past, Current & Future Analysis for Small Volume Parenteral by Indication Type - Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 348: Iran Historic Review for Small Volume Parenteral by Indication Type - Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 349: Iran 15-Year Perspective for Small Volume Parenteral by Indication Type - Percentage Breakdown of Value Sales for Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 350: Iran Recent Past, Current & Future Analysis for Small Volume Parenteral by Dose Type - Single-dose and Multiple-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 351: Iran Historic Review for Small Volume Parenteral by Dose Type - Single-dose and Multiple-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 352: Iran 15-Year Perspective for Small Volume Parenteral by Dose Type - Percentage Breakdown of Value Sales for Single-dose and Multiple-dose for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 353: Israel Recent Past, Current & Future Analysis for Small Volume Parenteral by Form - Liquid and Dry - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 354: Israel Historic Review for Small Volume Parenteral by Form - Liquid and Dry Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 355: Israel 15-Year Perspective for Small Volume Parenteral by Form - Percentage Breakdown of Value Sales for Liquid and Dry for the Years 2015, 2025 & 2030
    • TABLE 356: Israel Recent Past, Current & Future Analysis for Small Volume Parenteral by Packaging Type - Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 357: Israel Historic Review for Small Volume Parenteral by Packaging Type - Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 358: Israel 15-Year Perspective for Small Volume Parenteral by Packaging Type - Percentage Breakdown of Value Sales for Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles for the Years 2015, 2025 & 2030
    • TABLE 359: Israel Recent Past, Current & Future Analysis for Small Volume Parenteral by Indication Type - Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 360: Israel Historic Review for Small Volume Parenteral by Indication Type - Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 361: Israel 15-Year Perspective for Small Volume Parenteral by Indication Type - Percentage Breakdown of Value Sales for Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 362: Israel Recent Past, Current & Future Analysis for Small Volume Parenteral by Dose Type - Single-dose and Multiple-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 363: Israel Historic Review for Small Volume Parenteral by Dose Type - Single-dose and Multiple-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 364: Israel 15-Year Perspective for Small Volume Parenteral by Dose Type - Percentage Breakdown of Value Sales for Single-dose and Multiple-dose for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 365: Saudi Arabia Recent Past, Current & Future Analysis for Small Volume Parenteral by Form - Liquid and Dry - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 366: Saudi Arabia Historic Review for Small Volume Parenteral by Form - Liquid and Dry Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 367: Saudi Arabia 15-Year Perspective for Small Volume Parenteral by Form - Percentage Breakdown of Value Sales for Liquid and Dry for the Years 2015, 2025 & 2030
    • TABLE 368: Saudi Arabia Recent Past, Current & Future Analysis for Small Volume Parenteral by Packaging Type - Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 369: Saudi Arabia Historic Review for Small Volume Parenteral by Packaging Type - Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 370: Saudi Arabia 15-Year Perspective for Small Volume Parenteral by Packaging Type - Percentage Breakdown of Value Sales for Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles for the Years 2015, 2025 & 2030
    • TABLE 371: Saudi Arabia Recent Past, Current & Future Analysis for Small Volume Parenteral by Indication Type - Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 372: Saudi Arabia Historic Review for Small Volume Parenteral by Indication Type - Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 373: Saudi Arabia 15-Year Perspective for Small Volume Parenteral by Indication Type - Percentage Breakdown of Value Sales for Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 374: Saudi Arabia Recent Past, Current & Future Analysis for Small Volume Parenteral by Dose Type - Single-dose and Multiple-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 375: Saudi Arabia Historic Review for Small Volume Parenteral by Dose Type - Single-dose and Multiple-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 376: Saudi Arabia 15-Year Perspective for Small Volume Parenteral by Dose Type - Percentage Breakdown of Value Sales for Single-dose and Multiple-dose for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 377: UAE Recent Past, Current & Future Analysis for Small Volume Parenteral by Form - Liquid and Dry - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 378: UAE Historic Review for Small Volume Parenteral by Form - Liquid and Dry Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 379: UAE 15-Year Perspective for Small Volume Parenteral by Form - Percentage Breakdown of Value Sales for Liquid and Dry for the Years 2015, 2025 & 2030
    • TABLE 380: UAE Recent Past, Current & Future Analysis for Small Volume Parenteral by Packaging Type - Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 381: UAE Historic Review for Small Volume Parenteral by Packaging Type - Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 382: UAE 15-Year Perspective for Small Volume Parenteral by Packaging Type - Percentage Breakdown of Value Sales for Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles for the Years 2015, 2025 & 2030
    • TABLE 383: UAE Recent Past, Current & Future Analysis for Small Volume Parenteral by Indication Type - Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 384: UAE Historic Review for Small Volume Parenteral by Indication Type - Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 385: UAE 15-Year Perspective for Small Volume Parenteral by Indication Type - Percentage Breakdown of Value Sales for Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 386: UAE Recent Past, Current & Future Analysis for Small Volume Parenteral by Dose Type - Single-dose and Multiple-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 387: UAE Historic Review for Small Volume Parenteral by Dose Type - Single-dose and Multiple-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 388: UAE 15-Year Perspective for Small Volume Parenteral by Dose Type - Percentage Breakdown of Value Sales for Single-dose and Multiple-dose for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 389: Rest of Middle East Recent Past, Current & Future Analysis for Small Volume Parenteral by Form - Liquid and Dry - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 390: Rest of Middle East Historic Review for Small Volume Parenteral by Form - Liquid and Dry Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 391: Rest of Middle East 15-Year Perspective for Small Volume Parenteral by Form - Percentage Breakdown of Value Sales for Liquid and Dry for the Years 2015, 2025 & 2030
    • TABLE 392: Rest of Middle East Recent Past, Current & Future Analysis for Small Volume Parenteral by Packaging Type - Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 393: Rest of Middle East Historic Review for Small Volume Parenteral by Packaging Type - Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 394: Rest of Middle East 15-Year Perspective for Small Volume Parenteral by Packaging Type - Percentage Breakdown of Value Sales for Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles for the Years 2015, 2025 & 2030
    • TABLE 395: Rest of Middle East Recent Past, Current & Future Analysis for Small Volume Parenteral by Indication Type - Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 396: Rest of Middle East Historic Review for Small Volume Parenteral by Indication Type - Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 397: Rest of Middle East 15-Year Perspective for Small Volume Parenteral by Indication Type - Percentage Breakdown of Value Sales for Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 398: Rest of Middle East Recent Past, Current & Future Analysis for Small Volume Parenteral by Dose Type - Single-dose and Multiple-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 399: Rest of Middle East Historic Review for Small Volume Parenteral by Dose Type - Single-dose and Multiple-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 400: Rest of Middle East 15-Year Perspective for Small Volume Parenteral by Dose Type - Percentage Breakdown of Value Sales for Single-dose and Multiple-dose for the Years 2015, 2025 & 2030
  • AFRICA
    • Small Volume Parenteral Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 401: Africa Recent Past, Current & Future Analysis for Small Volume Parenteral by Form - Liquid and Dry - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 402: Africa Historic Review for Small Volume Parenteral by Form - Liquid and Dry Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 403: Africa 15-Year Perspective for Small Volume Parenteral by Form - Percentage Breakdown of Value Sales for Liquid and Dry for the Years 2015, 2025 & 2030
    • TABLE 404: Africa Recent Past, Current & Future Analysis for Small Volume Parenteral by Packaging Type - Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 405: Africa Historic Review for Small Volume Parenteral by Packaging Type - Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 406: Africa 15-Year Perspective for Small Volume Parenteral by Packaging Type - Percentage Breakdown of Value Sales for Other Packaging Types, Ampoules, Vials, Pre-filled Syringes, Cartridges and Bottles for the Years 2015, 2025 & 2030
    • TABLE 407: Africa Recent Past, Current & Future Analysis for Small Volume Parenteral by Indication Type - Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 408: Africa Historic Review for Small Volume Parenteral by Indication Type - Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 409: Africa 15-Year Perspective for Small Volume Parenteral by Indication Type - Percentage Breakdown of Value Sales for Pain Management, Cancer Care, Malnourishment, Gastrointestinal disorder / Diarrhea, Diabetes and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 410: Africa Recent Past, Current & Future Analysis for Small Volume Parenteral by Dose Type - Single-dose and Multiple-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 411: Africa Historic Review for Small Volume Parenteral by Dose Type - Single-dose and Multiple-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 412: Africa 15-Year Perspective for Small Volume Parenteral by Dose Type - Percentage Breakdown of Value Sales for Single-dose and Multiple-dose for the Years 2015, 2025 & 2030

IV. COMPETITION